References
- ADAM, Inc 2005. Heart attack and acute coronary syndrome (available at: http://adam.about.com/reports/000012_4.htm, , ) (accessed on 27 May 2005).
- Abd-Elfattah AS, Higgins RSD, Latifi R, Merrell RC. Targeting post-ischemic repurfusion injury: scientific dream and clinical reality. New Surgery 2001; 1: 41–51
- Beyerle K. POC testing of cardiac markers enhances ED care. Nursing Management 2002; 33(9)37–39
- Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SAA, Rios CN, Sugiyama CE, Ha C. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clinical Chemistry 2003; 49(4)581–585
- Coudray C, Favier A. Determination of salicylate hydroxylation products as an in-vivo oxidative stress marker. Free Radical Biology and Medicine 2000; 29(11)1064–1070
- Dohm M. 2004. Origin and maintenance of the Hsd:ICR random-bred strain (available at: http://www2.hawaii.edu/approximately dohm/Phd/OriginHsd.htm, , ) (accessed on 7 November 2004).
- Dorner T, Rieder A. Risk management of coronary heart disease-prevention. Wiener Medizinische Wochenschrift 2004; 154(11–12)257–265
- IUPAC. 1997, Fenton and Haber–Weiss reactions. IUPAC Compendium of Chemical Terminology 69: 1274–1277.
- Lees K. 2000. Multiple marker test quickly identifies high-risk heart attack patients, study says. Heart Signs, Duke University News and Communications (available at: http://www.dukenews.duke.edu/2000/09/heart901_print.htm, , ) (accessed on 27 May 2005).
- Luo J, Jankowski V, Gungar N, Neumann J, Schmitz W, Zidek W, Schluter H, Jankowski J. Endogenous diadensoine tetraphosphate, diadensoine pentaphosphate, and diadenosine hexaphosphate in human myocardial tissue. Hypertension 2004; 43(5)1055–1059
- Mei DA, Gross GJ, Nithipatikom K. Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector. Analytical Biochemistry 1996; 238: 34–39
- Morrow DA, De Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clinical Chemistry 2003; 49(4)537–539
- Naudziunas A, Jankauskiene L, Kalinauskiene E, Pilvinis V. Implementation of the patient education about cardiovascular risk factors into a daily routine of the Cardiology Unit of the hospital. Preventive Medicine 2005; 41(2)570–574
- Nelson D, Cox M. Lehninger principles of biochemistry3rd ed. Worth, New York, NY 2000; 848–868
- Okrainec K, Banerjee DK, Eisenburg MJ. Coronary artery disease in the developing world. American Heart Journal 2004; 148(1)7–15
- Onodera T, Ashraf M. Detection of hydroxyl radicals in the post-ischemic reperfused heart using salicylate as a trapping agent. Journal Molecular Cellular Cardiology 1991; 23: 365–370
- Tardif J, Bourassa M. Antioxidants and cardiovascular disease. Kluwer, Dordrecht 2000; 57–70
- Viegas TX, Omura GA, Stoltz RR, Kisick J. Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers. Journal Clinical Pharmacology 2000; 40: 410–420
- Xi L, Hess ML, Kukreja RC. Ischemic preconditioning in isolated perfused mouse heart: Reduction in infarct size without improvement of post-ischemic ventricular function. Molecular and Cellular Biochemistry 1998; 186: 69–77